Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

Summary

The development of clots is a potentially deadly complication in many cancer patients. The current optimal treatment is unknown. Evidence supporting the effectiveness of the use of Inferior Vena Caval Filters is lacking. This study will compare the two standard of care treatment options: anticoagulation with or without a inferior vena cava filter. The anticoagulation medication chosen will be Arixtra and it will be given once a day as an injection. Patients will be called at various intervals to monitor their signs and symptoms of new thromboembolisms.

Timeline

Start

2007-01

Primary completion

2010-11

Completion

2010-11

Drugs

Indications